{"hands_on_practices": [{"introduction": "Once you have eluted your nucleic acid, the first critical question is, \"How much did I recover?\". The most common method for quantifying DNA and RNA is ultraviolet-visible (UV-Vis) spectrophotometry, which relies on the Beer–Lambert law. This practice [@problem_id:5143481] will guide you through calculating the concentration and total mass of a DNA sample from its absorbance at $260\\,\\text{nm}$, a fundamental skill for any molecular biology workflow.", "problem": "A double-stranded deoxyribonucleic acid (dsDNA) extract prepared from formalin-fixed paraffin-embedded (FFPE) tissue is resuspended in a buffered aqueous medium and measured in a spectrophotometer at wavelength $260\\,\\text{nm}$. The instrument employs a cuvette with calibrated optical pathlength $l = 0.5\\,\\text{cm}$, and the baseline has been corrected using a matched buffer blank. The measured absorbance is $A_{260} = 0.120$. Use the Beer–Lambert relation as the fundamental starting point and the well-established dsDNA mass absorptivity convention that an absorbance of $1.00$ in a $1.00\\,\\text{cm}$ path corresponds to a mass concentration of $50\\,\\mu\\text{g}\\,\\text{mL}^{-1}$ at $260\\,\\text{nm}$. Equivalently, use the reciprocal mass extinction factor $\\varepsilon = 50\\,\\mu\\text{g}\\,\\text{mL}^{-1}$ per absorbance unit per centimeter so that the mass concentration $c_{m}$ satisfies $c_{m} = \\left(\\frac{A_{260}}{l}\\right)\\varepsilon$. \n\nAssuming the dsDNA behaves ideally with respect to absorbance per unit mass (fragmentation from FFPE processing does not change the mass absorptivity) and that protein and phenolic contaminants are negligible at $260\\,\\text{nm}$ after baseline correction, compute:\n- the dsDNA concentration $c_{m}$ in $\\mu\\text{g}\\,\\text{mL}^{-1}$, and\n- the total dsDNA mass $m_{\\text{tot}}$ contained in a final eluate volume of $50\\,\\mu\\text{L}$.\n\nRound your reported values to three significant figures. Express the final concentration in $\\mu\\text{g}\\,\\text{mL}^{-1}$ and the final mass in $\\mu\\text{g}$. Report your final answer as a two-entry row vector $\\begin{pmatrix} c_{m} & m_{\\text{tot}} \\end{pmatrix}$.", "solution": "The problem requires the calculation of the concentration and total mass of a double-stranded deoxyribonucleic acid (dsDNA) sample based on a spectrophotometric measurement. The fundamental principle governing this measurement is the Beer–Lambert law, which relates the absorbance of light by a substance to its concentration and the pathlength of the light through the sample. The law is generally expressed as:\n$$A = k c l$$\nwhere $A$ is the absorbance (a dimensionless quantity), $k$ is the absorptivity coefficient, $c$ is the concentration of the absorbing species, and $l$ is the optical pathlength.\n\nThe problem provides a specific formulation of this relationship for the mass concentration, $c_m$, of dsDNA at a wavelength of $260\\,\\text{nm}$:\n$$c_{m} = \\left(\\frac{A_{260}}{l}\\right)\\varepsilon$$\nHere, $A_{260}$ is the absorbance measured at $260\\,\\text{nm}$, $l$ is the pathlength in $\\text{cm}$, and $\\varepsilon$ is a conversion factor, stated to be $50\\,\\mu\\text{g}\\,\\text{mL}^{-1}$ per absorbance unit per centimeter. This value is the established convention for dsDNA, signifying that a solution with a mass concentration of $50\\,\\mu\\text{g}\\,\\text{mL}^{-1}$ yields an absorbance of $1.00$ in a cuvette with a $1.00\\,\\text{cm}$ pathlength.\n\nThe provided data are:\n- Measured absorbance: $A_{260} = 0.120$\n- Cuvette pathlength: $l = 0.5\\,\\text{cm}$\n- Conversion factor: $\\varepsilon = 50\\,\\mu\\text{g}\\,\\text{mL}^{-1}$\n- Final eluate volume: $V_{\\text{eluate}} = 50\\,\\mu\\text{L}$\n\nThe problem requires rounding the final calculated values to three significant figures. This implies that the given parameters should be treated as having at least this level of precision (i.e., $l=0.500\\,\\text{cm}$, $\\varepsilon=50.0\\,\\mu\\text{g}\\,\\text{mL}^{-1}$, and $V_{\\text{eluate}}=50.0\\,\\mu\\text{L}$).\n\nFirst, we calculate the dsDNA concentration, $c_m$. By substituting the given values into the provided equation:\n$$c_{m} = \\left(\\frac{0.120}{0.500\\,\\text{cm}}\\right) \\times 50.0\\,\\frac{\\mu\\text{g}}{\\text{mL}}$$\n$$c_{m} = 0.240\\,\\text{cm}^{-1} \\times 50.0\\,\\frac{\\mu\\text{g}}{\\text{mL}}$$\n$$c_{m} = 12.0\\,\\frac{\\mu\\text{g}}{\\text{mL}}$$\nThe concentration of the dsDNA solution is $12.0\\,\\mu\\text{g}\\,\\text{mL}^{-1}$.\n\nNext, we calculate the total mass of dsDNA, $m_{\\text{tot}}$, contained in the final eluate volume of $50\\,\\mu\\text{L}$. The total mass is the product of the concentration and the volume:\n$$m_{\\text{tot}} = c_{m} \\times V_{\\text{eluate}}$$\nTo ensure consistency of units, we must convert the volume from microliters ($\\mu\\text{L}$) to milliliters ($\\text{mL}$), using the conversion factor $1\\,\\text{mL} = 1000\\,\\mu\\text{L}$.\n$$V_{\\text{eluate}} = 50.0\\,\\mu\\text{L} \\times \\frac{1\\,\\text{mL}}{1000\\,\\mu\\text{L}} = 0.0500\\,\\text{mL}$$\nNow, we can calculate the total mass:\n$$m_{\\text{tot}} = \\left(12.0\\,\\frac{\\mu\\text{g}}{\\text{mL}}\\right) \\times (0.0500\\,\\text{mL})$$\n$$m_{\\text{tot}} = 0.600\\,\\mu\\text{g}$$\nThe total mass of dsDNA in the eluate is $0.600\\,\\mu\\text{g}$.\n\nThe final answer consists of the concentration $c_m$ and the total mass $m_{\\text{tot}}$, reported as a two-entry row vector.", "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n12.0 & 0.600\n\\end{pmatrix}\n}\n$$", "id": "5143481"}, {"introduction": "A high yield of nucleic acid is useless if the sample is contaminated with inhibitors from the extraction process. This exercise [@problem_id:5143246] presents a realistic scenario where spectrophotometric purity ratios indicate significant contamination with proteins, phenol, or chaotropic salts. You will apply your knowledge of extraction chemistry and enzyme kinetics to diagnose the problem and select the most effective cleanup strategy to rescue a downstream reverse transcription quantitative polymerase chain reaction (RT-qPCR) experiment.", "problem": "An investigator extracts ribonucleic acid (RNA) from formalin-fixed paraffin-embedded (FFPE) colon tissue using guanidinium thiocyanate, acid phenol, and a silica spin column. Ultraviolet absorbance spectra yield $A_{260}/A_{280} = 1.6$ and $A_{260}/A_{230} = 1.2$. The investigator plans reverse transcription quantitative polymerase chain reaction (RT-qPCR) assays targeting short amplicons ($\\le 100\\,\\mathrm{bp}$) due to anticipated fragmentation in FFPE RNA. From first principles, justify which corrective cleanup steps are most appropriate and predict the direction of change in key RT-qPCR readouts (cycle threshold $C_t$ and amplification efficiency $E$), assuming the cleanup is effective. Use as your fundamental base: the Beer–Lambert law $A = \\epsilon c l$, the characteristic absorbance of nucleic acids, proteins, phenol, and chaotropic salts at $230\\,\\mathrm{nm}$, $260\\,\\mathrm{nm}$, and $280\\,\\mathrm{nm}$, and basic enzyme kinetics of reverse transcriptase and deoxyribonucleic acid (DNA) polymerase.\n\nWhich option most correctly specifies both a cleanup strategy and its justified impact on downstream RT-qPCR performance under these conditions?\n\nA. Perform a chloroform-only back extraction (no phenol) followed by solid-phase reversible immobilization (SPRI) bead cleanup with an added $70\\%$ ethanol wash and an extended dry spin, then elute in nuclease-free water; expect $A_{260}/A_{280}$ and $A_{260}/A_{230}$ to increase toward $2.0$–$2.2$, $C_t$ to decrease, and $E$ to move toward $\\approx 0.95\\text{--}1.05$.\n\nB. Add ethylenediaminetetraacetic acid (EDTA) to $10\\ \\mathrm{mM}$ and proceed without further cleanup to chelate divalent cations; expect lower $C_t$ and improved $E$ because magnesium-dependent inhibitors are removed, and $A_{260}/A_{230}$ will increase because EDTA does not absorb at $230\\ \\mathrm{nm}$.\n\nC. Repeat extraction with acid phenol:chloroform and do not perform additional washes; expect $A_{260}/A_{280}$ to increase by removing proteins, $A_{260}/A_{230}$ to increase by removing salts, and RT-qPCR $C_t$ to decrease with $E$ approaching the ideal.\n\nD. Perform on-column deoxyribonuclease I (DNase I) digestion only; expect $A_{260}/A_{280}$ and $A_{260}/A_{230}$ to normalize and RT-qPCR $C_t$ to decrease primarily because genomic DNA is removed, even if phenol and chaotropic salts are present.\n\nE. Incubate the RNA with proteinase K at $56^{\\circ}\\mathrm{C}$ for $30\\ \\mathrm{min}$, then buffer-exchange through a desalting spin column into nuclease-free water; expect removal of proteins to normalize $A_{260}/A_{280}$, with minimal effect on $A_{260}/A_{230}$, and RT-qPCR $C_t$ to decrease without risk to RNA integrity in FFPE samples.", "solution": "### Problem Validation\n\n**Step 1: Extract Givens**\n- **Sample Type**: Ribonucleic acid (RNA) extracted from formalin-fixed paraffin-embedded (FFPE) colon tissue.\n- **Extraction Method**: Use of guanidinium thiocyanate, acid phenol, and a silica spin column.\n- **Purity Metrics**: Ultraviolet absorbance spectra yield an absorbance ratio $A_{260}/A_{280} = 1.6$ and an absorbance ratio $A_{260}/A_{230} = 1.2$.\n- **Downstream Application**: Reverse transcription quantitative polymerase chain reaction (RT-qPCR).\n- **Assay Design**: Targeting short amplicons ($\\le 100\\,\\mathrm{bp}$) due to anticipated RNA fragmentation in FFPE samples.\n- **Task**: To justify the most appropriate corrective cleanup steps and predict the resulting changes in RT-qPCR cycle threshold ($C_t$) and amplification efficiency ($E$).\n- **Governing Principles**: The Beer–Lambert law ($A = \\epsilon c l$), characteristic absorbances of nucleic acids, proteins, phenol, and chaotropic salts at $230\\,\\mathrm{nm}$, $260\\,\\mathrm{nm}$, and $280\\,\\mathrm{nm}$, and basic enzyme kinetics of reverse transcriptase and DNA polymerase.\n\n**Step 2: Validate Using Extracted Givens**\n- **Scientifically Grounded**: The problem statement is firmly based on established principles and practices of molecular biology. FFPE tissue processing, RNA extraction using guanidinium thiocyanate and phenol, purity assessment via spectrophotometry, and RT-qPCR are all standard laboratory procedures. The provided absorbance ratios are realistic indicators of common contamination issues.\n- **Well-Posed**: The problem is well-posed. It provides specific initial conditions (the absorbance ratios) that point to a definite problem (contamination) and asks for a logical solution and a prediction of its outcome based on fundamental principles. A unique, best solution among the options can be reasoned.\n- **Objective**: The language is technical, precise, and free of subjective or ambiguous terminology. All metrics ($A_{260}/A_{280}$, $A_{260}/A_{230}$, $C_t$, $E$) are standard, quantifiable parameters in molecular diagnostics.\n\n**Step 3: Verdict and Action**\nThe problem statement is scientifically sound, well-posed, objective, and complete. It is therefore deemed **valid**. A solution will be derived.\n\n### Derivation and Solution\n\n**1. Analysis of Initial Sample Purity from First Principles**\n\nThe Beer–Lambert law, $A = \\epsilon c l$, relates absorbance ($A$) to the molar extinction coefficient ($\\epsilon$), concentration ($c$), and path length ($l$). Spectrophotometric ratios such as $A_{260}/A_{280}$ are useful for purity assessment because the concentration and path length terms cancel, leaving a ratio dependent on the relative absorbance of the components in the mixture.\n\n- **Absorbance at $260\\,\\mathrm{nm}$ ($A_{260}$)**: This is the wavelength of maximum absorbance for nucleic acids (both RNA and DNA) due to the aromatic character of their purine and pyrimidine bases.\n- **Absorbance at $280\\,\\mathrm{nm}$ ($A_{280}$)**: This is the wavelength of maximum absorbance for proteins, primarily due to the aromatic rings of tryptophan and tyrosine residues. Phenol, a common reagent in nucleic acid extraction, also absorbs strongly near this wavelength (maximum $\\approx 270\\,\\mathrm{nm}$, but with significant absorbance at $280\\,\\mathrm{nm}$).\n- **Absorbance at $230\\,\\mathrm{nm}$ ($A_{230}$)**: This wavelength is sensitive to a variety of organic contaminants and other substances, notably chaotropic salts (e.g., guanidinium thiocyanate, guanidinium hydrochloride), phenolates, and peptide bonds in proteins.\n\n**Interpretation of Given Ratios:**\n- For pure RNA, the expected $A_{260}/A_{280}$ ratio is $\\approx 2.0$. The measured ratio of $1.6$ is significantly low, indicating the presence of contaminants that absorb more strongly at $280\\,\\mathrm{nm}$ relative to $260\\,\\mathrm{nm}$ than RNA does. The primary culprits are contaminating **proteins** and/or residual **phenol** from the acid phenol extraction step.\n- For pure RNA, the expected $A_{260}/A_{230}$ ratio is in the range of $2.0-2.2$. The measured ratio of $1.2$ is severely low, indicating substantial contamination with substances absorbing at $230\\,\\mathrm{nm}$. Given the extraction method, this is attributable to carryover of **chaotropic salts** (guanidinium thiocyanate) and/or **phenol**.\n\n**Conclusion on Sample State**: The RNA sample is significantly contaminated with residual guanidinium thiocyanate and either phenol, protein, or both.\n\n**2. Impact of Contaminants on RT-qPCR**\n\nRT-qPCR involves two critical enzymatic steps:\n1.  **Reverse Transcription**: A reverse transcriptase (RT) enzyme synthesizes complementary DNA (cDNA) from the RNA template.\n2.  **Quantitative PCR (qPCR)**: A thermostable DNA polymerase amplifies the cDNA, with fluorescence monitored in real-time.\n\nBoth RT and DNA polymerase are sensitive to inhibitors.\n- **Guanidinium salts**: As potent chaotropic agents, they disrupt the tertiary structure of proteins, including enzymes, and are powerful inhibitors of both reverse transcriptase and DNA polymerase.\n- **Phenol**: A strong organic solvent that denatures proteins. Even trace amounts will severely inhibit or completely abolish enzyme activity.\n- **Proteins**: Nonspecific protein contamination can interfere with enzyme access to the template. Contaminating nucleases (RNases) would degrade the RNA template.\n\n**Effect on RT-qPCR Parameters:**\n- **Cycle Threshold ($C_t$)**: This is the PCR cycle number where the fluorescent signal of the reaction crosses a background threshold. Inhibition of the enzymes reduces the rate of product accumulation. For a given starting quantity of template, inhibition will result in a delayed amplification curve and therefore a **higher $C_t$ value**.\n- **Amplification Efficiency ($E$)**: This measures the fold-increase in product per cycle. An ideal reaction has $E \\approx 1$ (or $100\\%$), meaning the product doubles each cycle. Inhibitors cause incomplete or failed primer extension, reducing the efficiency to $E < 1$.\n\nAn effective cleanup must remove these inhibitors. If successful, the $C_t$ for the same amount of template RNA will **decrease**, and the efficiency $E$ will **increase** toward its ideal value (typically accepted as $0.9-1.1$, or $90\\%-110\\%$).\n\n### Option-by-Option Analysis\n\n**A. Perform a chloroform-only back extraction (no phenol) followed by solid-phase reversible immobilization (SPRI) bead cleanup with an added $70\\%$ ethanol wash and an extended dry spin, then elute in nuclease-free water; expect $A_{260}/A_{280}$ and $A_{260}/A_{230}$ to increase toward $2.0$–$2.2$, $C_t$ to decrease, and $E$ to move toward $\\approx 0.95\\text{--}1.05$.**\n\n- **Cleanup Strategy**: This is a robust and multi-pronged approach.\n    - The **chloroform-only back extraction** is excellent for removing residual phenol from the aqueous phase without re-introducing it.\n    - **Solid-phase reversible immobilization (SPRI) bead cleanup** is a highly effective method for purifying nucleic acids. It efficiently removes proteins, salts, unincorporated nucleotides, and other small molecules.\n    - An **added $70\\%$ ethanol wash** is crucial for thoroughly removing salts (like guanidinium thiocyanate) that are soluble in ethanol while the RNA remains bound to the beads.\n    - The **extended dry spin** is critical to remove all traces of ethanol, which itself is a PCR inhibitor.\n- **Predicted Impact**:\n    - **Ratios**: Removing proteins and phenol will increase the $A_{260}/A_{280}$ ratio. Removing salts and phenol will increase the $A_{260}/A_{230}$ ratio. The target of $2.0-2.2$ is the ideal range for pure RNA. This prediction is correct.\n    - **RT-qPCR**: By removing potent enzymatic inhibitors (phenol, salts, excess protein), the efficiency of both reverse transcription and PCR will be restored. This will lead to a **lower $C_t$** and an **increase in $E$** toward the ideal range of $95\\%-105\\%$ ($E \\approx 1.0$). This prediction is correct.\n- **Verdict**: **Correct**. This option proposes a comprehensive and scientifically sound cleanup protocol that directly addresses the diagnosed contaminants. The predicted outcomes are entirely consistent with first principles.\n\n**B. Add ethylenediaminetetraacetic acid (EDTA) to $10\\ \\mathrm{mM}$ and proceed without further cleanup to chelate divalent cations; expect lower $C_t$ and improved $E$ because magnesium-dependent inhibitors are removed, and $A_{260}/A_{230}$ will increase because EDTA does not absorb at $230\\ \\mathrm{nm}$.**\n\n- **Cleanup Strategy**: This is not a cleanup. Ethylenediaminetetraacetic acid (EDTA) chelates divalent cations like $\\mathrm{Mg}^{2+}$. Both reverse transcriptase and DNA polymerase are metalloenzymes that critically require $\\mathrm{Mg}^{2+}$ as a cofactor for their catalytic activity. Adding EDTA to a final concentration of $10\\ \\mathrm{mM}$ would sequester the $\\mathrm{Mg}^{2+}$ in the RT-qPCR master mix, thereby severely **inhibiting** the enzymes.\n- **Predicted Impact**: The premise \"magnesium-dependent inhibitors are removed\" is unfounded; the main inhibitors are salts and phenol. The prediction of a lower $C_t$ and improved $E$ is the opposite of what would occur. The effect on absorbance ratios is irrelevant as the primary contaminants are not removed.\n- **Verdict**: **Incorrect**. This proposed action is biochemically counterproductive and is based on a fundamental misunderstanding of the enzyme cofactor requirements.\n\n**C. Repeat extraction with acid phenol:chloroform and do not perform additional washes; expect $A_{260}/A_{280}$ to increase by removing proteins, $A_{260}/A_{230}$ to increase by removing salts, and RT-qPCR $C_t$ to decrease with $E$ approaching the ideal.**\n\n- **Cleanup Strategy**: The sample is already contaminated with phenol and salts. Repeating an extraction with **more** acid phenol risks increasing phenol carryover. Critically, the instruction to **not perform additional washes** would guarantee that the chaotropic salts from the original lysis buffer remain in the sample. This strategy fails to address the root causes of contamination.\n- **Predicted Impact**: While a re-extraction might remove more protein, the failure to remove salts and the risk of adding more phenol would likely lead to worse, not better, RT-qPCR performance. The $A_{260}/A_{230}$ ratio would not increase.\n- **Verdict**: **Incorrect**. The proposed strategy is ill-advised and would likely exacerbate, rather than solve, the contamination issues.\n\n**D. Perform on-column deoxyribonuclease I (DNase I) digestion only; expect $A_{260}/A_{280}$ and $A_{260}/A_{230}$ to normalize and RT-qPCR $C_t$ to decrease primarily because genomic DNA is removed, even if phenol and chaotropic salts are present.**\n\n- **Cleanup Strategy**: This strategy only addresses potential genomic DNA (gDNA) contamination. It does nothing to remove the chemical contaminants (phenol, salts) that were identified by the low absorbance ratios.\n- **Predicted Impact**: The statement that RT-qPCR will improve \"even if phenol and chaotropic salts are present\" is fundamentally false. These chemicals are potent enzyme inhibitors that will cripple the reaction regardless of gDNA presence. Their removal is the primary requirement. Furthermore, removing gDNA would not \"normalize\" the absorbance ratios, which are depressed due to the chemical, not DNA, contaminants.\n- **Verdict**: **Incorrect**. This option misdiagnoses the primary problem. The chemical inhibition is the critical issue to be solved, and this strategy ignores it completely.\n\n**E. Incubate the RNA with proteinase K at $56^{\\circ}\\mathrm{C}$ for $30\\ \\mathrm{min}$, then buffer-exchange through a desalting spin column into nuclease-free water; expect removal of proteins to normalize $A_{260}/A_{280}$, with minimal effect on $A_{260}/A_{230}$, and RT-qPCR $C_t$ to decrease without risk to RNA integrity in FFPE samples.**\n\n- **Cleanup Strategy**: Proteinase K digestion will remove protein contaminants, and a desalting column will remove salts. This is a plausible, albeit less robust, strategy than option A.\n- **Predicted Impact**: The prediction contains a key flaw. It states there will be \"**minimal effect on $A_{260}/A_{230}$**\". This is incorrect. The low $A_{260}/A_{230}$ ratio is primarily due to salt contamination, and a desalting column is specifically designed to remove salts. Therefore, a successful desalting step should cause a **significant increase** in the $A_{260}/A_{230}$ ratio. Additionally, the claim of \"without risk to RNA integrity\" is an overstatement; incubating already fragile FFPE RNA at $56^{\\circ}\\mathrm{C}$ introduces a non-zero risk of heat-driven degradation.\n- **Verdict**: **Incorrect**. While the strategy has some merit, the predicted outcome contains a scientific inconsistency regarding the effect on the $A_{260}/A_{230}$ ratio, making the entire option incorrect.", "answer": "$$\\boxed{A}$$", "id": "5143246"}, {"introduction": "For demanding applications like Next-Generation Sequencing (NGS), especially when working with inherently degraded material from FFPE tissues, assessing the structural integrity of the RNA is paramount. This practice [@problem_id:5143397] introduces the DV200 metric, a key industry standard for evaluating RNA fragmentation. You will learn how to combine data from technical replicates to calculate a robust quality score and use it to make a critical go/no-go decision for an expensive sequencing run.", "problem": "A Formalin-Fixed Paraffin-Embedded (FFPE) tissue block is processed for ribonucleic acid (RNA) extraction, yielding a fragment size distribution measured by capillary electrophoresis across three independent technical replicates of the same lysate. The DV200 value is defined as the fraction of RNA fragments whose length exceeds $200$ nucleotides. Each replicate assays exactly $N_1=N_2=N_3=1.0 \\times 10^{6}$ fragments, and the observed fractions of fragments longer than $200$ nucleotides are $0.20$, $0.40$, and $0.60$ for replicates $1$, $2$, and $3$, respectively. \n\nStarting from the core definition that DV200 is the probability $p$ that a randomly sampled fragment has length $>200$ nucleotides, and modeling each assayed fragment as an independent Bernoulli trial with success probability $p$, derive from first principles the maximum-likelihood pooled estimator for DV200 given the three replicates. Then compute its numerical value for the data provided. Express the final DV200 as a decimal fraction with no unit, and round your answer to four significant figures.\n\nSeparately, based on well-tested facts about the tolerance of $3'$ messenger RNA sequencing ($3'$ mRNA-seq) to degraded RNA (e.g., typical acceptability when DV200 is approximately $0.30$ or higher), state whether the sample is suitable for $3'$ mRNA-seq and justify your decision qualitatively.", "solution": "The problem requires the derivation of the maximum-likelihood pooled estimator for the DV200 value from three technical replicates, a numerical calculation of this estimator, and a qualitative assessment of the sample's suitability for $3'$ mRNA-sequencing.\n\n**Problem Validation**\nThe problem is scientifically grounded in standard molecular biology and biostatistics principles (RNA quality control, maximum likelihood estimation). It is well-posed, providing all necessary data and definitions for a unique solution. The language is objective and the scenario is realistic. Consequently, the problem is deemed valid and a full solution will be provided.\n\n**Part 1: Derivation of the Maximum-Likelihood Pooled Estimator for DV200**\n\nLet $p$ represent the true, unknown DV200 value. This is defined as the probability that a randomly selected RNA fragment from the lysate has a length greater than $200$ nucleotides. Each fragment assayed is modeled as an independent Bernoulli trial, where 'success' is a fragment length exceeding $200$ nucleotides. The probability of success is $p$.\n\nWe are given data from $3$ independent technical replicates. For each replicate $i \\in \\{1, 2, 3\\}$:\n- $N_i$ is the total number of fragments assayed.\n- $k_i$ is the number of fragments observed to have a length greater than $200$ nucleotides.\n\nThe number of successes $k_i$ in $N_i$ trials follows a binomial distribution, with the probability mass function given by:\n$$P(k_i | N_i, p) = \\binom{N_i}{k_i} p^{k_i} (1-p)^{N_i - k_i}$$\n\nSince the three replicates are independent measurements of the same lysate, they share the same underlying success probability $p$. The joint likelihood function $L(p)$ for observing the set of outcomes $\\{k_1, k_2, k_3\\}$ given the sample sizes $\\{N_1, N_2, N_3\\}$ is the product of the individual probabilities:\n$$L(p | \\{k_i\\}, \\{N_i\\}) = \\prod_{i=1}^{3} P(k_i | N_i, p) = \\prod_{i=1}^{3} \\binom{N_i}{k_i} p^{k_i} (1-p)^{N_i - k_i}$$\n\nTo find the maximum likelihood estimator (MLE) for $p$, denoted $\\hat{p}_{MLE}$, we must find the value of $p$ that maximizes $L(p)$. It is analytically more convenient to maximize the natural logarithm of the likelihood function, the log-likelihood $\\ell(p)$:\n$$\\ell(p) = \\ln(L(p)) = \\ln\\left( \\prod_{i=1}^{3} \\binom{N_i}{k_i} p^{k_i} (1-p)^{N_i - k_i} \\right)$$\nUsing the properties of logarithms, this simplifies to:\n$$\\ell(p) = \\sum_{i=1}^{3} \\ln\\left( \\binom{N_i}{k_i} p^{k_i} (1-p)^{N_i - k_i} \\right) = \\sum_{i=1}^{3} \\left( \\ln\\binom{N_i}{k_i} + k_i \\ln(p) + (N_i - k_i) \\ln(1-p) \\right)$$\nTo find the maximum, we compute the first derivative of $\\ell(p)$ with respect to $p$ and set it to zero:\n$$\\frac{d\\ell}{dp} = \\frac{d}{dp} \\left[ \\left( \\sum_{i=1}^{3} \\ln\\binom{N_i}{k_i} \\right) + \\ln(p) \\left( \\sum_{i=1}^{3} k_i \\right) + \\ln(1-p) \\left( \\sum_{i=1}^{3} (N_i - k_i) \\right) \\right] = 0$$\nThe derivative is:\n$$\\frac{d\\ell}{dp} = \\frac{1}{p} \\sum_{i=1}^{3} k_i - \\frac{1}{1-p} \\sum_{i=1}^{3} (N_i - k_i) = 0$$\nRearranging the terms to solve for the estimator $\\hat{p}$:\n$$\\frac{\\sum k_i}{\\hat{p}} = \\frac{\\sum N_i - \\sum k_i}{1 - \\hat{p}}$$\n$$ (1 - \\hat{p}) \\sum k_i = \\hat{p} \\left( \\sum N_i - \\sum k_i \\right) $$\n$$ \\sum k_i - \\hat{p} \\sum k_i = \\hat{p} \\sum N_i - \\hat{p} \\sum k_i $$\n$$ \\sum k_i = \\hat{p} \\sum N_i $$\nThe maximum-likelihood pooled estimator for $p$ is therefore:\n$$\\hat{p}_{MLE} = \\frac{\\sum_{i=1}^{3} k_i}{\\sum_{i=1}^{3} N_i}$$\nThis demonstrates from first principles that the MLE for the common probability $p$ is the total number of successes across all replicates divided by the total number of trials.\n\n**Part 2: Numerical Calculation of the DV200 Estimator**\n\nThe problem provides the following data:\n- Number of fragments per replicate: $N_1 = N_2 = N_3 = 1.0 \\times 10^6$.\n- Observed fractions of fragments with length $> 200$ nucleotides: $f_1 = 0.20$, $f_2 = 0.40$, $f_3 = 0.60$.\n\nFirst, we calculate the number of successes, $k_i$, for each replicate:\n$k_1 = f_1 \\times N_1 = 0.20 \\times (1.0 \\times 10^6) = 200,000$.\n$k_2 = f_2 \\times N_2 = 0.40 \\times (1.0 \\times 10^6) = 400,000$.\n$k_3 = f_3 \\times N_3 = 0.60 \\times (1.0 \\times 10^6) = 600,000$.\n\nNext, we calculate the total number of successes, $K_{total} = \\sum k_i$, and the total number of trials, $N_{total} = \\sum N_i$:\n$K_{total} = 200,000 + 400,000 + 600,000 = 1,200,000 = 1.2 \\times 10^6$.\n$N_{total} = (1.0 \\times 10^6) + (1.0 \\times 10^6) + (1.0 \\times 10^6) = 3.0 \\times 10^6$.\n\nUsing the derived MLE formula:\n$$\\hat{p}_{MLE} = \\frac{K_{total}}{N_{total}} = \\frac{1.2 \\times 10^6}{3.0 \\times 10^6} = 0.4$$\nSince the sample sizes $N_i$ are equal, the pooled estimate is equivalent to the arithmetic mean of the individual fractions:\n$$\\hat{p}_{MLE} = \\frac{f_1 + f_2 + f_3}{3} = \\frac{0.20 + 0.40 + 0.60}{3} = \\frac{1.20}{3} = 0.4$$\nThe problem requires the answer to be expressed to four significant figures. Therefore, the numerical value for the estimated DV200 is $0.4000$.\n\n**Part 3: Assessment of Suitability for 3' mRNA-seq**\n\nThe problem states that a sample is typically considered acceptable for $3'$ mRNA-seq if its DV200 is approximately $0.30$ or higher. Our calculated pooled estimate for the DV200 is $\\hat{p}_{MLE} = 0.4000$.\n\nComparing our result to the given threshold:\n$$0.4000 \\ge 0.30$$\nThe condition is satisfied. Therefore, the sample is deemed suitable for $3'$ mRNA-seq.\n\nThe justification is as follows: The pooled DV200 value of $0.4000$ represents the best estimate of the sample's overall RNA quality, indicating that $40\\%$ of the RNA fragments are longer than $200$ nucleotides. This value exceeds the typical minimum requirement of $30\\%$ for $3'$ mRNA-seq applications. This type of sequencing is inherently robust to the RNA degradation characteristic of FFPE samples because it primarily requires the capture of the $3'$ end of messenger RNA molecules via their polyadenylated (poly-A) tails for cDNA synthesis. Even if the full-length transcript is fragmented, a fragment containing the poly-A tail and an upstream portion of the transcript is sufficient for generating a sequenceable library. A DV200 of $0.4000$ provides confidence that a sufficient quantity of such informative fragments exists in the sample to yield meaningful gene expression data.", "answer": "$$\\boxed{0.4000}$$", "id": "5143397"}]}